dicetylphosphate has been researched along with B16 Melanoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asai, T; Dewa, T; Kenjo, E; Nango, M; Oku, N; Shimizu, K; Tsuruta, A; Yonenaga, N | 1 |
Ando, H; Asai, T; Dewa, T; Hatanaka, K; Ishii, T; Kenjo, E; Nango, M; Oku, N; Shimizu, K; Tsukada, H; Urita, Y; Yonenaga, N | 1 |
2 other study(ies) available for dicetylphosphate and B16 Melanoma
Article | Year |
---|---|
RGD-based active targeting of novel polycation liposomes bearing siRNA for cancer treatment.
Topics: Animals; Cations; Cell Line, Tumor; Drug Carriers; Ethylenediamines; Genetic Therapy; Liposomes; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Oligopeptides; Organophosphates; Polyethylene Glycols; RNA Interference; RNA, Small Interfering; Xenograft Model Antitumor Assays | 2012 |
Systemic delivery of small interfering RNA by use of targeted polycation liposomes for cancer therapy.
Topics: Animals; Cell Proliferation; Ethylenediamines; Liposomes; Lung; Lung Neoplasms; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Organophosphates; Peptides, Cyclic; Polyethylene Glycols; Proto-Oncogene Proteins c-mdm2; RNA, Small Interfering; Salivary alpha-Amylases; Vascular Endothelial Growth Factor A | 2013 |